Dr. Julie Bolcaen is a postdoctoral researcher at the Nuclear Medicine Department, Radiation Biophysics Division, NRF iThemba LABS, South Africa. Her main research focus lies in the field of radiobiology and theranostics with the goal to validate new cancer radiosensitizers and radiopharmaceuticals. Dr. Bolcaen graduated as a Master in Biomedical Sciences (option Radiation Science) in 2011 and obtained her Ph.D. in Health Sciences at Ghent University (Belgium) in 2017. During her Ph.D. she performed clinical and preclinical research in the field of molecular imaging in neuro-oncology at the department of Nuclear Medicine of Ghent University. Her Ph.D. focused on PET/MRI imaging of brain tumors and small animal irradiation. She has contributed to 15 peer-reviewed publications, including 10 as a first author. She is a member of SARS and SNMMI and received a young investigator award at the ICRR in 2019.